| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0035-9203(01)90207-X |
| P698 | PubMed publication ID | 11579891 |
| P2093 | author name string | Curtis J | |
| Curtis CF | |||
| Maxwell CA | |||
| Mkongewa S | |||
| Msuya FH | |||
| Mutabingwa TK | |||
| Sia IG | |||
| Vannithone S | |||
| P2860 | cites work | A comparison of use of a pyrethroid either for house spraying or for bednet treatment against malaria vectors | Q38958357 |
| In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment | Q38958423 | ||
| Comparison of bednets impregnated with different pyrethroids for their impact on mosquitoes and on re-infection with malaria after clearance of pre-existing infections with chlorproguanil-dapsone | Q39227785 | ||
| High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania | Q39416558 | ||
| Insecticide-impregnated bed nets reduce malaria transmission in rural Zanzibar. | Q39491087 | ||
| Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone | Q39533597 | ||
| Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. | Q39557015 | ||
| Clinical pharmacokinetics of dapsone | Q39743290 | ||
| Clinical pharmacokinetics of antimalarial drugs | Q39824441 | ||
| The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses | Q41913682 | ||
| In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected | Q41917730 | ||
| Resistance to chloroquine and sulfadoxine-pyrimethamine in Plasmodium falciparum in Muheza district, Tanzania | Q41923176 | ||
| Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians. | Q41931375 | ||
| Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype | Q43951490 | ||
| Trial of pyrethroid impregnated bednets in an area of Tanzania holoendemic for malaria Part 4. Effects on incidence of malaria infection | Q43956152 | ||
| Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals | Q43961974 | ||
| Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range | Q46154949 | ||
| Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study | Q46595521 | ||
| Pyrimethamine resistant mutations in Plasmodium falciparum | Q47860951 | ||
| Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during regular long term malaria prophylaxis | Q47885603 | ||
| Plasmodium falciparum: mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient | Q48033279 | ||
| Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates | Q48036946 | ||
| Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand | Q58477006 | ||
| In vitro inhibition of granulopoiesis by 4-amino-4'-hydroxylaminodiphenyl sulfone | Q71351506 | ||
| Chemotherapy for falciparum malaria: the armoury, the problems and the prospects | Q33868231 | ||
| The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria | Q34402882 | ||
| Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria. | Q34743292 | ||
| Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya | Q35170521 | ||
| P433 | issue | 4 | |
| P921 | main subject | Tanzania | Q924 |
| Plasmodium falciparum | Q311383 | ||
| pyrimethamine | Q421072 | ||
| P304 | page(s) | 433-438 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Transactions of the Royal Society of Tropical Medicine and Hygiene | Q15766916 |
| P1476 | title | A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania | |
| P478 | volume | 95 |
| Q39284402 | Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial |
| Q39149127 | Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response |
| Q35398338 | Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali |
| Q36895753 | Folate metabolism as a source of molecular targets for antimalarials. |
| Q41946040 | Fractions of an antimalarial neem-leaf extract have activities superior to chloroquine, and are gametocytocidal |
| Q39366015 | Geographic distribution of amino acid mutations in DHFR and DHPS in Plasmodium vivax isolates from Lao PDR, India and Colombia |
| Q36023624 | How do patients use antimalarial drugs? A review of the evidence |
| Q37433820 | Implementing Intermittent Preventive Treatment for Malaria in Pregnancy: Review of Prospects, Achievements, Challenges and Agenda for Research |
| Q24814180 | Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern Tanzania |
| Q33997904 | Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications |
| Q35541782 | Monitoring antimalarial drug resistance: making the most of the tools at hand |
| Q34191903 | Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax |
| Q24814023 | Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug |
| Q60156116 | Science, medicine, and the future: Malaria |
| Q39351643 | The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate |
Search more.